 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-13-2019
Insider Buy |
Sandeep Laumas
CEO, Executive Chairman |
$1.22
CAGR »
|
$1,215.91
1,000 shares |
5-30-2019
Insider Buy |
Jay P. Madan
President |
$1.32
CAGR »
|
$6,600.00
5,000 shares |
5-22-2019
Insider Buy |
Sandeep Laumas
CEO, Executive Chairman |
$1.38
CAGR »
|
$6,900.00
5,000 shares |
11-30-2018
Insider Buy |
Sandeep Laumas
Executive Chairman |
$2.63
CAGR »
|
$7,890.00
3,000 shares |
11-30-2018
Insider Buy |
Roy Proujansky
Director |
$2.63
CAGR »
|
$3,682.00
1,400 shares |
11-29-2018
Insider Buy |
Christopher P. Prior
Chief Executive Officer |
$2.75
CAGR »
|
$13,750.00
5,000 shares |
11-29-2018
Insider Buy |
Sandeep Laumas
Executive Chairman |
$2.56
CAGR »
|
$7,670.00
3,000 shares |
9-14-2018
Insider Buy |
Christopher P. Prior
Chief Executive Officer |
$5.82
CAGR »
|
$1,164.00
200 shares |
9-12-2018
Insider Buy |
Christopher P. Prior
Chief Executive Officer |
$6.13
CAGR »
|
$3,065.00
500 shares |
9-7-2018
Insider Buy |
Sandeep Laumas
Executive Chairman |
$6.10
CAGR »
|
$3,050.00
500 shares |
8-28-2018
Insider Buy |
Sandeep Laumas
Executive Chairman |
$4.90
CAGR »
|
$1,225.00
250 shares |
8-30-2018
Insider Buy |
Christopher P. Prior
Chief Executive Officer |
$5.20
CAGR »
|
$1,606.80
309 shares |
8-28-2018
Insider Buy |
Sandeep Laumas
Executive Chairman |
$5.01
CAGR »
|
$3,759.05
750 shares |
8-28-2018
Insider Buy |
Christopher P. Prior
Chief Executive Officer |
$4.93
CAGR »
|
$4,930.00
1,000 shares |
8-27-2018
Insider Buy |
June Sherie Almenoff
COO and Chief Medical Officer |
$4.92
CAGR »
|
$6,885.18
1,400 shares |
1-26-2018
Insider Buy |
David H. Clarke
Former CEO and Director |
$0.59
CAGR »
|
$542,271.67
923,573 shares |
Also See: Institutional Holders of INNT
Also See: SEC filings
Below we present the annualized performance delivered by INNT stock since 6-13-2019 (the date of the most recent
insider purchase). The performance of the investment from the time INNT insider buying occurred is the ultimate
test of whether insiders were right about INNT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/14/2019 |
|
| End date: |
05/01/2020 |
|
| Start price/share: |
$1.18 |
|
| End price/share: |
$0.56 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-52.54% |
|
| Annualized Gain: |
-59.56% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,746.00 |
|
| Years: |
0.88 |
|
INNT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent INNT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding INNT
|
|
Free INNT Email Alerts:
